As the pharmaceutical industry braces for a new wave of blockbuster drugs going off-patent—a phenomenon known as the "patent cliff"—the immediate conversation usually revolves around declining revenues for originators and opportunities for generic manufacturers. But beyond drug formulation and distribution, there lies a strategic, often overlooked opportunity: packaging, labeling, and artwork management.
- Today is: